West Virginia Healthcare Press: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on West Virginia Healthcare Press.

Press releases published on June 4, 2026

9 hours ago

Quoin Pharmaceuticals Announces Japan's MHLW Grants Orphan Drug Designation for QRX003 in Netherton Syndrome

Indeterminate GlobeNewswire

9 hours ago

Fate Therapeutics Showcases Data from FT819 and FT839 Programs at the European Congress of Rheumatology Annual Meeting

Indeterminate GlobeNewswire

9 hours ago

Oncotelic Therapeutics Inc. (OTCQB: OTLC) Eyeing Nanotech-Driven Delivery Systems, Pharmacokinetic Optimization to Advance Existing Oncology Therapies

Indeterminate GlobeNewswire

9 hours ago

NewGen Doubles Down on K25.ai with Additional US$4 Million Stake and Adopts Digital Asset Treasury Strategy

Indeterminate GlobeNewswire

9 hours ago

TOMI Environmental Solutions, Inc. Scales Food Safety Presence with SteraMist Hybrid Installation at Expanded Food Facility

Indeterminate GlobeNewswire

9 hours ago

Prenetics Appoints Hudson Leogrande, Founder and CEO of Multi-Billion-Dollar DTC Brand Comfrt, to Board of Directors as IM8 Accelerates TikTok and Meta Expansion

Indeterminate GlobeNewswire

9 hours ago

Amneal Announces U.S. FDA Approval of Romidepsin Injection Solution

Indeterminate GlobeNewswire

9 hours ago

NXTC Announces Replay Available for Virtual KOL Event Discussing ASCO 2026 Dose Escalation Data from Phase 1 Trial of SIM0505 for Gynecologic Cancers

Indeterminate GlobeNewswire

9 hours ago

Drew Brees Collaborates with ARS Pharmaceuticals to Raise Awareness About Living Life with Severe Allergies

Indeterminate GlobeNewswire

9 hours ago

Celularity and Fountain Life Announce Availability of Cenplacel-L for Investigational Use Under New Florida Law, Establishing Scalable Pathway for Advancement of Placental-Derived Cell Therapies

Indeterminate GlobeNewswire

9 hours ago

Immutep to Present Positive Interim Phase I Data for IMP761, a First-in-Class LAG-3 Agonist Antibody, at EULAR 2026

Indeterminate GlobeNewswire

9 hours ago

IMUNON Announces Up to $10 Million Cash Financing

Indeterminate GlobeNewswire

9 hours ago

Melanoma Research Alliance Appoints Stephanie Kauffman as Chief Executive Officer

Indeterminate GlobeNewswire

9 hours ago

Weight Watchers to Increase Access to Comprehensive Weight Loss Options for Patients Nationwide through LillyDirect

Indeterminate GlobeNewswire

9 hours ago

Arvinas Joins The Michael J. Fox Foundation’s LITE and PPMI Programs to Advance New Therapies Targeting LRRK2 for Parkinson’s Disease

Indeterminate GlobeNewswire

9 hours ago

Daré Bioscience Announces the Upcoming Launch of Flora Sync LF5™ Vaginal Probiotic Capsules

Indeterminate GlobeNewswire

9 hours ago

Arch Biopartners Featured in American Diabetes Association Thought Leadership Series at the 2026 Scientific Sessions in New Orleans

Indeterminate GlobeNewswire

10 hours ago

SciSparc: Subsidiary NeuroThera Labs Completed Acquisition of CliniQuantum

Indeterminate GlobeNewswire

10 hours ago

Onco360® Has Been Selected as a National Specialty Pharmacy Provider for JYLAMVO® (methotrexate) Oral Solution

Indeterminate GlobeNewswire

10 hours ago

Plus Therapeutics Announces CAP Accreditation of CNSide® Diagnostics Clinical Laboratory

Indeterminate GlobeNewswire